Epilim Chrono 500mg tablets contain sodium valproate in a modified release formulation. This prescription medication is designed to prevent epileptic seizures and treat bipolar disorder. Its extended-release technology provides consistent therapeutic effects throughout the day, improving patient compliance and quality of life.
Uses
Epilim Chrono 500mg is primarily prescribed for managing epilepsy, including both generalized and partial seizures. Additionally, it’s used to treat acute manic episodes associated with bipolar disorder. The medication’s central nervous system effects make it valuable in controlling these neurological and psychiatric conditions.
Benefits
- Reduces frequency and severity of epileptic seizures
- Stabilizes mood swings in bipolar disorder patients
- Helps control psychotic symptoms and impulsive behavior
- Improves overall quality of life for patients
- Provides consistent therapeutic effects due to modified release formulation
- May reduce the need for multiple medications in some patients
How It Works
Sodium valproate, the active ingredient in Epilim Chrono, works through multiple mechanisms. It modulates GABA activity, enhancing this inhibitory neurotransmitter’s effects in the brain. The medication also blocks voltage-gated sodium channels and enhances GABA subtype receptor functioning. These combined actions help dampen seizure activity and stabilize extreme mood fluctuations.
Dosage
Treatment typically begins with lower doses, around 500mg daily, and may be increased up to 2000mg daily based on clinical indicators and patient response. Epilim Chrono requires twice-daily administration due to its modified release formulation. It’s crucial to follow the prescribing physician’s advice regarding dosage and administration schedule.
Side Effects
Common side effects may include nausea, tremor, and weight gain. More serious side effects, though rare, can include liver dysfunction and pancreatitis. Patients should report any unusual symptoms to their healthcare provider promptly.
Warning
Epilim Chrono 500mg can cause drowsiness or dizziness, potentially affecting activities requiring alertness. Abrupt cessation after long-term use should be avoided due to the risk of withdrawal seizures. Regular blood monitoring is essential to check liver function and platelet counts.
Pregnancy and Breastfeeding
Epilim Chrono 500mg is contraindicated during pregnancy due to the high risk of congenital malformations and developmental disorders in the fetus. Women of childbearing age must use effective contraception during treatment. Breastfeeding while taking this medication is not recommended.
Interaction
- May interact with other anticonvulsants, altering their effectiveness
- Can enhance the effects of CNS depressants like alcohol
- May affect the metabolism of certain antidepressants and antipsychotics
- Potential interaction with anticoagulants, requiring close monitoring
- May interfere with some laboratory tests, particularly those for thyroid function
Important Information
Patients should report any signs of depression, suicidal thoughts, or liver issues (such as jaundice or abdominal pain) immediately. Seek urgent medical care if signs of an allergic reaction appear, including rash, itching, or swelling. Regular compliance checks and medical monitoring are essential for safe and effective use of Epilim Chrono. Patients should not adjust their dosage or stop taking the medication without consulting their healthcare provider.
Product Image Gallery
Customer questions & answers
There are no questions yet. Be the first to ask a question about this product.
Tailored to Your Needs
-
₦23,000.00Rated 0 out of 5
Epanutin is used for controlling generalized tonic-clonic seizures and partial...
-
₦15,500.00Rated 0 out of 5
Suvitra Tablet is an anticonvulsant medication used to treat various...
-
₦16,500.00Rated 0 out of 5
Neuracalm tablets contain a combination of pregabalin and methylcobalamin for...
-
₦5,000.00Rated 0 out of 5
Pitrofin Syrup is used to treat and prevent various types...
Reviews
There are no reviews yet.